Coronary artery disease and heart failure Circulatory System Coronary artery disease and heart failure
Conditions
Interventions
1. Patients in the intervention group were provided with an internet-based telerehabilitation program in addition to conventional centre-based cardiac rehabilitation. The telerehabilitation program wa
if they had questions and/or technical difficulties, they were provided with technical support.
3. Patients receiving the intervention were prescribed literature on patient-specific ex
Sponsors
Flanders Care
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Coronary artery disease treated conservatively with percutaneous coronary intervention or coronary artery bypass graft 2. Chronic heart failure (CHF) with reduced ejection fraction (EF) 3. CHF and preserved EF 4. Current active rehabilitation in one of the recruiting centres 5. Patients with a personal computer with an internet connection 6. Age >18 and <80 7. Familiarity with the Dutch language 6. Patients who provided informed consent
Exclusion criteria
Exclusion criteria: 1. Orthopaedic or neurological condition or both, restricting the patient’s ability to actively engage in exercise training sessions 2. Impairment preventing the use of the telerehabilitation equipment or attendance at follow-up visits (terminal disease, dementia and cognitive impairment) 3. Simultaneous participation in another clinical trial 4. CHF New York Heart Association class IV 5. History of ventricular fibrillation, exertional sustained ventricular tachycardia or supraventricular tachycardia within the previous 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peak oxygen consumption (VO2 peak) at maximal cardiopulmonary exercise testing; measured at baseline, 6 weeks and 6-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Daily physical activity: defined as the total number of daily low intensity and high intensity steps and registered during the whole study by accelerometry data (measured continuously with an accelerometer) 2. Cardiovascular risk factor control: body weight, blood pressure, blood lipids, glucose and glycated haemoglobin measured at baseline and 6-month follow-up 3. HeartQol: quality of life score measured at baseline, 6 weeks and 6-month follow-up 4. International Physical Activity Questionnaire: physical activity score measured at baseline, 6 weeks and 6 months 5. EQ-5D score measured at 6 weeks and 6 months 6. Days lost due to cardiovascular rehospitalisation from the start to the end of the study 7. Days lost due to hospitalisation for any reason from the start to the end of the study 8. Time to first cardiovascular rehospitalisation from the start to the end of the study 9. Time to first hospitalisation for any reason from the start to the end of the study | — |
Countries
Belgium
Outcome results
None listed